<span id="midArticle_start"/> Zeltia SA :
<span id="midArticle_0"/>* PharmaMar finalizes patient recruitment in the phase IIIstudy of register (ADMYRE) with Aplidin in multiple myeloma
<span id="midArticle_1"/> <span class="first-article-divide"/>* The pivotal study will evaluate efficacy of plitidepsin incombination with dexamethasone against dexamethasone alone inpatients with relapse or refractory multiple myeloma
<span id="midArticle_2"/> <span class="second-article-divide"/>* The application for marketing authorization in Europe isexpected in 2016Source text for Eikon:
<span id="midArticle_3"/> <span class="third-article-divide"/>Further company coverage: (Gdynia Newsroom)
<span id="midArticle_4"/>
<span id="midArticle_0"/>* PharmaMar finalizes patient recruitment in the phase IIIstudy of register (ADMYRE) with Aplidin in multiple myeloma
<span id="midArticle_1"/> <span class="first-article-divide"/>* The pivotal study will evaluate efficacy of plitidepsin incombination with dexamethasone against dexamethasone alone inpatients with relapse or refractory multiple myeloma
<span id="midArticle_2"/> <span class="second-article-divide"/>* The application for marketing authorization in Europe isexpected in 2016Source text for Eikon:
<span id="midArticle_3"/> <span class="third-article-divide"/>Further company coverage: (Gdynia Newsroom)
<span id="midArticle_4"/>
via Smart Health Shop Forum http://ift.tt/1AESP6b
No comments:
Post a Comment